Immunovant Inc. Common Stock vs ONEOK Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while ONEOK Inc. Common Stock trades at $90.5 (market cap $55.51B). The key difference: ONEOK Inc. Common Stock is far larger — about 8.4× Immunovant Inc. Common Stock's market cap, and ONEOK Inc. Common Stock pays a 4.86% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and ONEOK Inc. Common Stock for 0 Days on average.
| IMVT | OKE | |
|---|---|---|
Market Cap | $6.62B | $55.51B |
Volume | 1,131,364 | 3,116,209 |
Sector | Health | Energy |
52-Week High | $44.96 | $97.51 |
52-Week Low | $17.03 | $64.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $88.37B |
Dividend Yield | — | 4.86% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →ONEOK operates energy infrastructure for natural gas, natural gas liquids, and crude oil. Its assets include pipelines, processing facilities, storage, and related services.
Read more on OKE →